Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Infection Prevention and Enteral Access Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Infection Prevention and Enteral Access Industry
  • 1.7 COVID-19 Impact: Infection Prevention and Enteral Access Market Trends

    • 2 Global Infection Prevention and Enteral Access Quarterly Market Size Analysis

    • 2.1 Infection Prevention and Enteral Access Business Impact Assessment - COVID-19
      • 2.1.1 Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Infection Prevention and Enteral Access Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Infection Prevention and Enteral Access Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Infection Prevention and Enteral Access Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Infection Prevention and Enteral Access Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Infection Prevention and Enteral Access Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Infection Prevention and Enteral Access Market
    • 3.5 Key Manufacturers Infection Prevention and Enteral Access Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Infection Prevention and Enteral Access Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Enteral Feeding Pumps
      • 1.4.2 Enteral Feeding Tubes
      • 1.4.3 Administration Reservoirs
      • 1.4.4 Giving Sets
      • 1.4.5 Enteral Syringes
    • 4.2 By Type, Global Infection Prevention and Enteral Access Market Size, 2019-2021
      • 4.2.1 By Type, Global Infection Prevention and Enteral Access Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Infection Prevention and Enteral Access Price, 2020-2021

    5 Impact of Covid-19 on Infection Prevention and Enteral Access Segments, By Application

    • 5.1 Overview
      • 5.5.1 Oncology
      • 5.5.2 Gastroenterology
      • 5.5.3 Diabetes
      • 5.5.4 Neurological Disorders
      • 5.5.5 Hypermetabolism
      • 5.5.6 Others
    • 5.2 By Application, Global Infection Prevention and Enteral Access Market Size, 2019-2021
      • 5.2.1 By Application, Global Infection Prevention and Enteral Access Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Infection Prevention and Enteral Access Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Cook Medical
      • 7.1.1 Cook Medical Business Overview
      • 7.1.2 Cook Medical Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.1.3 Cook Medical Infection Prevention and Enteral Access Product Introduction
      • 7.1.4 Cook Medical Response to COVID-19 and Related Developments
    • 7.2 Medtronic plc
      • 7.2.1 Medtronic plc Business Overview
      • 7.2.2 Medtronic plc Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.2.3 Medtronic plc Infection Prevention and Enteral Access Product Introduction
      • 7.2.4 Medtronic plc Response to COVID-19 and Related Developments
    • 7.3 Boston Scientific Corporation
      • 7.3.1 Boston Scientific Corporation Business Overview
      • 7.3.2 Boston Scientific Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Product Introduction
      • 7.3.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
    • 7.4 CONMED Corporation
      • 7.4.1 CONMED Corporation Business Overview
      • 7.4.2 CONMED Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.4.3 CONMED Corporation Infection Prevention and Enteral Access Product Introduction
      • 7.4.4 CONMED Corporation Response to COVID-19 and Related Developments
    • 7.5 CORPAK MedSystems
      • 7.5.1 CORPAK MedSystems Business Overview
      • 7.5.2 CORPAK MedSystems Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Product Introduction
      • 7.5.4 CORPAK MedSystems Response to COVID-19 and Related Developments
    • 7.6 CR Bard
      • 7.6.1 CR Bard Business Overview
      • 7.6.2 CR Bard Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.6.3 CR Bard Infection Prevention and Enteral Access Product Introduction
      • 7.6.4 CR Bard Response to COVID-19 and Related Developments
    • 7.7 ALCOR Scientific
      • 7.7.1 ALCOR Scientific Business Overview
      • 7.7.2 ALCOR Scientific Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.7.3 ALCOR Scientific Infection Prevention and Enteral Access Product Introduction
      • 7.7.4 ALCOR Scientific Response to COVID-19 and Related Developments
    • 7.8 Pacific Hospital Supply
      • 7.8.1 Pacific Hospital Supply Business Overview
      • 7.8.2 Pacific Hospital Supply Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Product Introduction
      • 7.8.4 Pacific Hospital Supply Response to COVID-19 and Related Developments
    • 7.9 Teleflexorporated
      • 7.9.1 Teleflexorporated Business Overview
      • 7.9.2 Teleflexorporated Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.9.3 Teleflexorporated Infection Prevention and Enteral Access Product Introduction
      • 7.9.4 Teleflexorporated Response to COVID-19 and Related Developments
    • 7.10 Vygon SA
      • 7.10.1 Vygon SA Business Overview
      • 7.10.2 Vygon SA Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
      • 7.10.3 Vygon SA Infection Prevention and Enteral Access Product Introduction
      • 7.10.4 Vygon SA Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Infection Prevention and Enteral Access Supply Chain Analysis
      • 8.1.1 Infection Prevention and Enteral Access Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Infection Prevention and Enteral Access Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Infection Prevention and Enteral Access Distribution Channels
      • 8.2.2 Covid-19 Impact on Infection Prevention and Enteral Access Distribution Channels
      • 8.2.3 Infection Prevention and Enteral Access Distributors
    • 8.3 Infection Prevention and Enteral Access Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Infection Prevention and Enteral Access, including the following market information:
      Global Infection Prevention and Enteral Access Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Infection Prevention and Enteral Access Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Infection Prevention and Enteral Access Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Infection Prevention and Enteral Access Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Cook Medical, Medtronic plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems, CR Bard, ALCOR Scientific, Pacific Hospital Supply, Teleflexorporated, Vygon SA, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Enteral Feeding Pumps
      Enteral Feeding Tubes
      Administration Reservoirs
      Giving Sets
      Enteral Syringes

      Based on the Application:
      Oncology
      Gastroenterology
      Diabetes
      Neurological Disorders
      Hypermetabolism
      Others

      Buy now